Articles

: ‘Barbie’ was the rare original-film summer blockbuster. It will not reverse the franchise flood.

As studios and advertisers search for takeaways, analysts say the success of "Barbie" will be hard to repeat and is unlikely to stop the deluge of franchise movies.

The Fed: Fed minutes show officials wary about the outlook and wanting to move carefully

Federal Reserve officials were uncertain and decided that they would move carefully in coming months, according to minutes of their September meeting.

: ‘Peeps’ and other foods that will be impacted by California’s ban on certain food additives

California Gov. Newsom said the law is a 'positive step forward' until the FDA reviews and establishes national regulations on the use of the four additives.

: Birkenstock’s stock falls 10% in trading debut after IPO priced at lower end of range

Birkenstock's stock opened at $41.20, or 10% below its issue price of $46.

: The ‘tragedy’ of American healthcare: Olympic gymnast Mary Lou Retton’s family is crowdsourcing for her hospital bills. She’s not alone.

GoFundMe campaigns for medical bills represent one-third of all the platform’s crowdsourcing efforts, but few reach their goal.

In One Chart: The housing market crashed 16 years ago. Why a repeat blowup looks unlikely.

U.S. home prices skyrocketed 20% during the pandemic, but froth in today's housing market looks less likely to spark another big blow up, says Goldman Sachs.

: Steve Scalise nominated for speaker by House Republicans

House Republicans nominated Steve Scalise as their speaker, turning to a key fundraiser and ally of the oil industry. He would replace Kevin McCarthy.

Brett Arends's ROI: Longtime stock-market bear Jeremy Grantham is probably right about this, history says

Retirement savers, take note: Longtime doomsayer has an investment tip.

Beth Pinsker: Retirement bond anxiety: Even with 6% yields, you can’t set and forget it

You can’t just lock in high yields and ride into the sunset. 

: Tempest Therapeutics’ stock jumps 1,900% as liver-cancer treatment shows promise

The drug candidate showed clinical superiority as a first-line treatment for unresectable or metastatic hepatocellular carcinoma, a common type of liver cancer.

Key Words: Pioneer’s CEO cheers Exxon’s ‘great dividend.’ Here’s how much he could make.

Pioneer Natural Resources CEO Scott Sheffield plans to keep all Exxon Mobil shares he gets as part of the companies' merger because of the "great dividend."

: Exxon, Pioneer deal is ‘home run’ for Exxon

Exxon Mobil Corp.'s all-stock bid for Pioneer Natural Resources Co. makes the integrated oil giant's North America holdings even more attractive for a relatively modest price.
1 1,718 1,719 1,720 1,721 1,722 2,158